Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A17551 | 27312947 | J Hepatol | MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. | 2016 | Details |
| A17555 | 26492845 | Clin Gastroenterol Hepatol | Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery. | 2015 | Details |
| A17562 | 27744419 | Aging (Albany NY) | Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans. | 2016 | Details |
| A17566 | 27743130 | Eur J Nutr | Efficacy and safety of fermented garlic extract on hepatic function in adults with elevated serum gamma-glutamyl transpeptidase levels: a double-blind, randomized, placebo-controlled trial. | 2016 | Details |
| A17568 | 27742550 | J Diabetes Complications | Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus. | 2016 | Details |
| A17570 | 27741171 | J Clin Gastroenterol | Gut Microbiota and the Liver: A Tale of 2 Cities: A Narrative View in 2 Acts. | 2017 | Details |
| A17572 | 27740519 | Ann Hepatol |  Chemerin, retinol binding protein-4, cytokeratin-18 and transgelin-2 presence in sera of patients with non-alcoholic liver fatty disease. | 2017 | Details |
| A17573 | 27740518 | Ann Hepatol |  Most overweight and obese Indian children have nonalcoholic fatty liver disease. | 2017 | Details |
| A17574 | 27739482 | Sci Rep | Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17584 | 27733959 | Cureus | Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17586 | 27732787 | Annu Rev Med | Nonalcoholic Steatohepatitis. | 2016 | Details |
| A17587 | 27732328 | J Clin Endocrinol Metab | Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study. | 2017 | Details |
| A17589 | 27730688 | Aliment Pharmacol Ther | Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms. | 2016 | Details |
| A17591 | 27729736 | World J Gastroenterol | Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17592 | 27729634 | Clin Mol Hepatol | Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment. | 2016 | Details |
| A17595 | 27727520 | Liver Int | The therapeutic landscape of non-alcoholic steatohepatitis. | 2016 | Details |
| A17599 | 27725647 | Am J Gastroenterol | Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis. | 2016 | Details |
| A17600 | 27723801 | PLoS One | Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice. | 2016 | Details |
| A17606 | 27721459 | Sci Rep | IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner. | 2016 | Details |
| A17609 | 27719652 | Curr Mol Med | Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature. | 2016 | Details |
| A17615 | 27714002 | Food Funct | The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: a randomized controlled intervention. | 2016 | Details |
| A17616 | 27713972 | Food Funct | Vascular- and hepato-protective effects of passion fruit seed extract containing piceatannol in chronic high-fat diet-fed rats. | 2016 | Details |
| A17617 | 27713108 | Environ Health Perspect | Chronic Exposure to Low Doses of Dioxin Promotes Liver Fibrosis Development in the C57BL/6J Diet-Induced Obesity Mouse Model. | 2016 | Details |
| A17621 | 27711128 | PLoS One | Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. | 2016 | Details |
| A17625 | 27709009 | Acta Pharm Sin B | Fatty liver diseases, bile acids, and FXR. | 2016 | Details |
| A17626 | 27708340 | Sci Rep | Activation and increase of radio-sensitive CD11b+ recruited Kupffer cells/macrophages in diet-induced steatohepatitis in FGF5 deficient mice. | 2016 | Details |
| A17628 | 27706836 | Hepatology | Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood. | 2016 | Details |
| A17634 | 27697615 | Gene | Integrative transcriptomic analysis of NAFLD animal model reveals dysregulated genes and pathways in metabolism. | 2016 | Details |
| A17637 | 27697366 | C R Biol | High carbohydrate diet induces nonalcoholic steato-hepatitis (NASH) in a desert gerbil. | 2016 | Details |
| A17638 | 27697327 | J Pediatr | The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis. | 2016 | Details |
| A17639 | 27695900 | Diabetologia | An oxidative stress paradox: time for a conceptual change? | 2016 | Details |
| A17641 | 27693527 | Life Sci | Effect of HFD/STZ on expression of genes involved in lipid, cholesterol and glucose metabolism in rats. | 2016 | Details |
| A17646 | 27690306 | Medwave | Liver steatosis and nonalcoholic steatohepatitis: from pathogenesis to therapy. | 2016 | Details |
| A17655 | 29416297 | Hippokratia | The adipokines in the pathogenesis and treatment of nonalcoholic fatty liver disease. | 2020 | Details |
| A17661 | 27680752 | Cell Biol Toxicol | Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health. | 2016 | Details |
| A17670 | 27672297 | World J Gastroenterol | Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease. | 2016 | Details |
| A17673 | 27669973 | Expert Rev Mol Med | C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication. | 2016 | Details |
| A17680 | 27663419 | J Hepatol | Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. | 2016 | Details |
| A17683 | 27660122 | Diabetes Care | Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities. | 2016 | Details |
| A17687 | 27658772 | Gastroenterology | Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease. | 2016 | Details |
| A17695 | 27650916 | Scand J Gastroenterol | Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease. | 2016 | Details |
| A17698 | 27649410 | PLoS One | Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17700 | 27649152 | Int J Mol Sci | Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C Virus. | 2016 | Details |
| A17704 | 27646933 | Gut | Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. | 2016 | Details |
| A17706 | 27642591 | Biomed Res Int | Perilla Oil Supplementation Ameliorates High-Fat/High-Cholesterol Diet Induced Nonalcoholic Fatty Liver Disease in Rats via Enhanced Fecal Cholesterol and Bile Acid Excretion. | 2016 | Details |
| A17709 | 27642348 | Hepat Mon | Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17714 | 27639593 | Transl Res | Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress. | 2016 | Details |
| A17716 | 27639192 | Hepatology | Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis. | 2016 | Details |
| A17717 | 27639088 | Hepatology | Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values. | 2016 | Details |
| A17722 | 27635163 | J Ultrasound | Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution. | 2016 | Details |
| A17727 | 27634010 | Am J Physiol Gastrointest Liver Physiol | Statins improve NASH via inhibition of RhoA and Ras. | 2016 | Details |
| A17732 | 27632911 | Nutr Res | Cynanchum wilfordii Radix attenuates liver fat accumulation and damage by suppressing hepatic cyclooxygenase-2 and mitogen-activated protein kinase in mice fed with a high-fat and high-fructose diet. | 2016 | Details |
| A17737 | 27628945 | J Dig Dis | MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease. | 2016 | Details |
| A17739 | 27628106 | Diabetologia | Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice. | 2016 | Details |
| A17740 | 27627981 | Diabetologia | Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial. | 2016 | Details |
| A17741 | 27627804 | PLoS One | Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17742 | 27626926 | Cell Physiol Biochem | Differential Lipotoxic Effects of Palmitate and Oleate in Activated Human Hepatic Stellate Cells and Epithelial Hepatoma Cells. | 2016 | Details |
| A17745 | 27624887 | Gut | Epigenetics in liver disease: from biology to therapeutics. | 2016 | Details |
| A17746 | 27624512 | Pediatrics | Lysosomal Acid Lipase Deficiency Unmasked in Two Children With Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17747 | 27623186 | Dig Liver Dis | Prevalence and predictors of liver steatosis and fibrosis in unselected patients with HIV mono-infection. | 2016 | Details |
| A17750 | 27621571 | World J Gastroenterol | Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? | 2016 | Details |
| A17753 | 27620899 | Psychopharmacology (Berl) | Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study. | 2016 | Details |
| A17759 | 27616339 | Scand J Gastroenterol | SAF score and mortality in NAFLD after up to 41 years of follow-up. | 2016 | Details |
| A17760 | 27615366 | Hepatol Res | Establishment of mouse Mac-2 binding protein enzyme-linked immunosorbent assay and its application for mouse chronic liver disease models. | 2016 | Details |
| A17762 | 27614103 | Liver Int | Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency. | 2016 | Details |
| A17765 | 27613713 | Toxicol Sci | From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis. | 2016 | Details |
| A17767 | 27612024 | Sci Rep | Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation. | 2016 | Details |
| A17768 | 27610012 | World J Gastroenterol | Metabolic aspects of adult patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A17772 | 27606822 | J Magn Reson Imaging | Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI. | 2016 | Details |
| A17775 | 27604194 | Thromb Haemost | ADAMTS13 deficiency promotes microthrombosis in a murine model of diet-induced liver steatosis. | 2016 | Details |
| A17781 | 27599824 | J Hepatol | Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. | 2016 | Details |
| A17782 | 27599521 | Gut | Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study. | 2016 | Details |
| A17784 | 27596100 | BMC Med Genet | The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH). | 2016 | Details |
| A17795 | 27582882 | Therap Adv Gastroenterol | Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis. | 2016 | Details |
| A17797 | 27581063 | Clin Gastroenterol Hepatol | Nonobese Fatty Liver Disease. | 2016 | Details |
| A17799 | 27580477 | J Clin Gastroenterol | The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population. | 2017 | Details |
| A17801 | 27577861 | Hepatol Res | Genetic prevention of hepatitis C virus-induced liver fibrosis by allele-specific downregulation of MERTK. | 2016 | Details |
| A17807 | 27571466 | Recenti Prog Med | [Non-alcoholic fatty liver disease (NAFLD)]. | 2016 | Details |
| A17814 | 27564402 | Expert Opin Pharmacother | Emerging and future therapies for nonalcoholic steatohepatitis in adults. | 2016 | Details |
| A17815 | 27563875 | Int J Mol Sci | Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17816 | 27563632 | Adv Biomed Res | Association between sonographic diagnosis of fatty liver with histopathologic abnormalities and liver biopsy findings in middle age patient with non-alcoholic fatty liver disease. | 2016 | Details |
| A17817 | 27563019 | Gut Liver | Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions. | 2016 | Details |
| A17819 | 27562557 | Toxicol Sci | Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis. | 2016 | Details |
| A17828 | 27549244 | Aliment Pharmacol Ther | Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. | 2016 | Details |
| A17830 | 27548720 | Dig Dis | Pathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction. | 2016 | Details |
| A17831 | 27548267 | Dig Dis | Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease. | 2016 | Details |
| A17832 | 27548138 | Int J Mol Sci | Chemokine-Like Receptor 1 mRNA Weakly Correlates with Non-Alcoholic Steatohepatitis Score in Male but Not Female Individuals. | 2016 | Details |
| A17834 | 27547937 | Dig Dis | How to Diagnose Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17842 | 27543499 | Br Med Bull | Non-alcoholic fatty liver disease in 2016. | 2016 | Details |
| A17846 | 27539153 | Hepatol Res | Emerging role of exosomes in liver physiology and pathology. | 2016 | Details |
| A17849 | 27535001 | Sci Rep | Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport. | 2016 | Details |
| A17850 | 27532276 | Hepatology | Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. | 2016 | Details |
| A17853 | 27523635 | Clin Gastroenterol Hepatol | Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis. | 2016 | Details |
| A17857 | 27521506 | Clin Gastroenterol Hepatol | New Pharmacologic Agents That Target Inflammation and Fibrosis in Nonalcoholic Steatohepatitis-Related Kidney Disease. | 2016 | Details |
| A17865 | 27514671 | Sci Rep | Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease. | 2016 | Details |
| A17866 | 27514483 | Am J Physiol Gastrointest Liver Physiol | Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in mice. | 2016 | Details |
| A17867 | 27514479 | Am J Physiol Gastrointest Liver Physiol | The kielin/chordin-like protein KCP attenuates nonalcoholic fatty liver disease in mice. | 2016 | Details |
| A17868 | 27513850 | Radiology | Detection of Steatohepatitis in a Rat Model by Using Spectroscopic Shear-Wave US Elastography. | 2016 | Details |
| A17870 | 27512874 | Medicine (Baltimore) | Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis. | 2016 | Details |
| A17871 | 27512407 | Nutr Metab (Lond) | High-fat but not sucrose intake is essential for induction of dyslipidemia and non-alcoholic steatohepatitis in guinea pigs. | 2016 | Details |